Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The SARM1 axon degeneration pathway: control of the NAD+ metabolome regulates axon survival in health and disease

Current Opinion in Neurobiology(2020)10.1016/j.conb.2020.02.012Source: DataRank Database

The SARM1 axon degeneration pathway: control of the NAD+ metabolome regulates axon survival in health and disease is a research paper published in Current Opinion in Neurobiology (2020). On theSindex it has a DataRank of 0. It has been cited 158 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access158 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 11.28)OA: greenTopics (32)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Aaron DiAntonio ORCID,Matthew D. Figley ORCID

Live enrichment

PubMed:32311648 PMC:PMC7483800 OpenAlex:https://openalex.org/W3017258409

National Institutes of Health

Grant: RO1NS087632

National Institutes of Health

Grant: R01CA219866

NINDS NIH HHS

Grant: R01 NS087632

FWCI

11.28

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

greenLicense: https://www.elsevier.com/legal/tdmrep-license

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7483800

publisherhttps://api.elsevier.com/content/article/PII:S0959438820300507?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0959438820300507?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.conb.2020.02.012

Fields of Study

Sirtuins and Resveratrol in MedicineVitamin C and Antioxidants ResearchAnesthesia and Neurotoxicity ResearchArmadillo Domain ProteinsAxonsCytoskeletal ProteinsHumansMetabolomeNADNicotinamide-Nucleotide AdenylyltransferaseWallerian Degeneration

MeSH Terms

AxonsCytoskeletal ProteinsHumansNADNicotinamide-Nucleotide AdenylyltransferaseWallerian DegenerationArmadillo Domain ProteinsMetabolome

Keywords

AxonMetabolomeNeuroscienceNAD+ kinaseDiseaseDegeneration (medical)BiologyMedicineBioinformaticsPathologyMetabolomicsBiochemistryEnzyme

Sustainable Development Goals

SDG 0: Good health and well-being

The SARM1 axon degeneration pathway: control of the NAD+ metabolome regulates axon survival in health and disease

FAIR Checklist

Authors (2)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)